Merck KGaA, Darmstadt, Germany, Selects illusive networks' Deceptions Everywhere Cybersecurity

illusive safeguards the intellectual property of the life science, healthcare and performance materials sectors in Merck KGaA Darmstadt, Germany against advanced cyber attacks

NEW YORK and TEL AVIV, Israel, May 30, 2017 /PRNewswire/ -- illusive networks [http://www.illusivenetworks.com/], the leader in Deceptions Everywhere® cybersecurity today announced that Merck KGaA, Darmstadt, Germany, a leading science and technology company, selected illusive to protect its vast network across the Americas, Europe, Africa, Asia, and Oceania from advanced cyber attacks.

The world's oldest pharmaceutical and chemical company selected illusive to supplement its existing security controls with a deception-based post-breach cybersecurity technology to neutralize targeted attacks and Advanced Persistent Threats (APTs) that make their way into the group's network.

"In today's hostile climate, you never know when a new vulnerability or a new bypass technique may arise," says Branden Newman, Head of Business Technology Security and Deputy CISO, Merck KGaA, Darmstadt, Germany. "Deception-based technologies are amongst the best to mitigate advanced attackers while providing a higher level of insight into the malicious activity. illusive networks offers the most innovative and effective approach to deception technology. Additionally, their solution is scalable and easy to deploy."

With increasingly complex Advanced Persistent Threats and cases of corporate espionage on the rise, the group aimed to enhance the protection of their intellectual property in the chemical and healthcare sectors, particularly their most sensitive data and zones. Bolstering their comprehensive security monitoring was also an objective to ensure the earliest detection and mitigation of cyber attacks, minimizing impact to their business operations.

illusive networks' award-winning agentless Deceptions Everywhere technology blankets a company's entire network -- every endpoint, server and network component - with information that deceives attackers. When attackers act upon the false information, illusive neutralizes the attack and triggers a detailed real-time breach report enabling security administrators to detect, track and contain the attack in its early stages.

"Even with security solutions deployed, every network is at risk to cyber attacks making post-breach cybersecurity an imperative to keep data safe," said Ofer Israeli, CEO, illusive networks. "With illusive's Deceptions Everywhere technology, Merck KGaA, Darmstadt, Germany has fortified its comprehensive security strategy by ensuring that any threats that bypass its perimeter controls are quickly detected and stopped. Selection by global companies along with a host of industry awards reaffirms illusive networks' leadership in the deceptions-based cybersecurity market."

About illusive networks illusive networks is pioneering deception-based cybersecurity with its patented Deceptions Everywhere® technology that neutralizes targeted attacks and Advanced Persistent Threats (APT) by creating a deceptive layer across the entire network. By providing an endless source of false information, illusive disrupts and detects attacks with real-time forensics and without disruption to business. For more information, please visit www.illusivenetworks.com [http://www.illusivenetworks.com/] or follow @illusivenw on Twitter and Facebook [https://www.facebook.com/illusivenetworks/].

CONTACT: Leron Kornreich, www.siliconvpr.com, leron@siliconvpr.com, 415.937.1724

Web site: http://www.illusivenetworks.com/

PR Newswire

Dit persbericht is via ANP Pers Support naar internationale (vak en online) media gestuurd. Heb je nieuws voor buitenlandse journalisten? Bekijk dan onze mogelijkheden of neem contact met ons op.

Verstuur nu éénmalig een persbericht

Verstuur persberichten en beeldmateriaal naar redacties in binnen- en buitenland. Via het ANP-net, het internationale medianetwerk van PR Newswire of met een perslijst op maat.

Direct persbericht versturen
070 - 41 41 234